Literature DB >> 36053750

Sexually dimorphic effects of SARM1 deletion on cardiac NAD+ metabolism and function.

Hina Lateef Nizami1, Keaton E Minor1,2, Ying Ann Chiao3,4, Christine M Light1, Chi Fung Lee1,2.   

Abstract

Nicotinamide adenine dinucleotide (NAD+) decline is repeatedly observed in heart disease and its risk factors. Although strategies promoting NAD+ synthesis to elevate NAD+ levels improve cardiac function, whether inhibition of NAD+ consumption can be therapeutic is less investigated. In this study, we examined the role of sterile-α and TIR motif containing 1 (SARM1) NAD+ hydrolase in mouse hearts, using global SARM1-knockout mice (KO). Cardiac function was assessed by echocardiography in male and female KO mice and wild-type (WT) controls. Hearts were collected for biochemical, histological, and molecular analyses. We found that the cardiac NAD+ pool was elevated in female KO mice, but only trended to increase in male KO mice. SARM1 deletion induced changes to a greater number of NAD+ metabolism transcripts in male mice than in female mice. Body weights, cardiac systolic and diastolic function, and geometry showed no changes in both male and female KO mice compared with WT counterparts. Male KO mice showed a small, but significant, elevation in cardiac collagen levels compared with WT counterparts, but no difference in collagen levels was detected in female mice. The increased collagen levels were associated with greater number of altered profibrotic and senescence-associated inflammatory genes in male KO mice, but not in female KO mice.NEW & NOTEWORTHY We examined the effects of SARM1 deletion on NAD+ pool, transcripts of NAD+ metabolism, and fibrotic pathway for the first time in mouse hearts. We observed the sexually dimorphic effects of SARM1 deletion. How these sex-dependent effects influence the outcomes of SARM1 deficiency in male and female mice in responses to cardiac stresses warrant further investigation. The elevation of cardiac NAD+ pool by SARM1 deletion provides evidence that targeting SARM1 may reverse disease-related NAD+ decline.

Entities:  

Keywords:  NAD metabolism; SARM1; cardiac dysfunction; sex differences

Mesh:

Substances:

Year:  2022        PMID: 36053750      PMCID: PMC9529255          DOI: 10.1152/ajpheart.00370.2022

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   5.125


  37 in total

1.  Disruption of CD38 gene enhances cardiac functions by elevating serum testosterone in the male null mice.

Authors:  Lu Gan; Wei Jiang; Yun-Fei Xiao; Lin Deng; Lun-Da Gu; Zhi-Yun Guo; Zhi-Chao Zhou; Dan Wu; Hong-Bo Xin
Journal:  Life Sci       Date:  2011-08-03       Impact factor: 5.037

2.  Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.

Authors:  Georgios Karamanlidis; Chi Fung Lee; Lorena Garcia-Menendez; Stephen C Kolwicz; Wichit Suthammarak; Guohua Gong; Margaret M Sedensky; Philip G Morgan; Wang Wang; Rong Tian
Journal:  Cell Metab       Date:  2013-08-06       Impact factor: 27.287

3.  Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure.

Authors:  Bo Zhou; Dennis Ding-Hwa Wang; Yanhua Qiu; Sophia Airhart; Yaxin Liu; April Stempien-Otero; Kevin D O'Brien; Rong Tian
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1.

Authors:  Yuefeng Jiang; Tingting Liu; Chia-Hsueh Lee; Qing Chang; Jing Yang; Zhe Zhang
Journal:  Nature       Date:  2020-10-14       Impact factor: 49.962

5.  Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Hugo J Aparicio; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Susan Cheng; Francesca N Delling; Mitchell S V Elkind; Kelly R Evenson; Jane F Ferguson; Deepak K Gupta; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Chong D Lee; Tené T Lewis; Junxiu Liu; Matthew Shane Loop; Pamela L Lutsey; Jun Ma; Jason Mackey; Seth S Martin; David B Matchar; Michael E Mussolino; Sankar D Navaneethan; Amanda Marma Perak; Gregory A Roth; Zainab Samad; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Andrew Stokes; Lisa B VanWagner; Nae-Yuh Wang; Connie W Tsao
Journal:  Circulation       Date:  2021-01-27       Impact factor: 29.690

6.  Reinforcing rigor and reproducibility expectations for use of sex and gender in cardiovascular research.

Authors:  Merry L Lindsey; Amanda J LeBlanc; Crystal M Ripplinger; Jason R Carter; Jonathan A Kirk; Kara Hansell Keehan; Keith R Brunt; Petra Kleinbongard; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-09-15       Impact factor: 4.733

7.  Sarm1 induction and accompanying inflammatory response mediates age-dependent susceptibility to rotenone-induced neurotoxicity.

Authors:  Malinki Sur; Puja Dey; Ankita Sarkar; Sudipta Bar; Dipanjana Banerjee; Swati Bhat; Piyali Mukherjee
Journal:  Cell Death Discov       Date:  2018-12-11

8.  Systemic loss of Sarm1 protects Schwann cells from chemotoxicity by delaying axon degeneration.

Authors:  Weili Tian; Tim Czopka; Hernán López-Schier
Journal:  Commun Biol       Date:  2020-01-30

9.  Structural basis for SARM1 inhibition and activation under energetic stress.

Authors:  Michael Sporny; Julia Guez-Haddad; Tami Khazma; Carsten Mim; Michail N Isupov; Ran Zalk; Michael Hons; Avraham Yaron; Moshe Dessau; Yoel Shkolnisky; Yarden Opatowsky
Journal:  Elife       Date:  2020-11-13       Impact factor: 8.140

10.  Live imaging reveals the cellular events downstream of SARM1 activation.

Authors:  Kwang Woo Ko; Laura Devault; Yo Sasaki; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Elife       Date:  2021-11-15       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.